These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29174065)

  • 1. Critique of inaccurate reporting in Edlavitch article on "Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: Example of a recent ondansetron publication".
    Fejzo MS; MacGibbon KW; Mullin PM
    Reprod Toxicol; 2018 Jan; 75():144-145. PubMed ID: 29174065
    [No Abstract]   [Full Text] [Related]  

  • 2. Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: Example of a recent ondansetron publication.
    Edlavitch SA
    Reprod Toxicol; 2017 Jan; 67():125-128. PubMed ID: 27988282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade.
    Danielsson B; Webster WS; Ritchie HE
    Reprod Toxicol; 2018 Oct; 81():237-245. PubMed ID: 30149139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Publication of unethical studies on the treatment of chemotherapy-induced emesis.
    Roila F; Tonato M; Del Favero A
    J Clin Oncol; 1991 May; 9(5):891-3. PubMed ID: 1826740
    [No Abstract]   [Full Text] [Related]  

  • 5. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.
    Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ
    N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.
    Habib AS; Gan TJ
    J Clin Anesth; 2005 Feb; 17(1):62-5. PubMed ID: 15721732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B
    Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
    Kwong WJ; Parasuraman TV
    Pharm Pract Manag Q; 1999 Apr; 19(1):28-41. PubMed ID: 10351607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antiemetic effects of ondansetron and dexamethasone on middle ear surgery.
    Isik B; Cekmen N; Arslan M; Ozsoylar O; Kordan AZ; Akcabay M
    Saudi Med J; 2006 May; 27(5):646-51. PubMed ID: 16680254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ondansetron for acute gastroenteritis in children.
    Mehta S; Goldman RD
    Can Fam Physician; 2006 Nov; 52(11):1397-8. PubMed ID: 17279195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy.
    Garra G; Singer AJ; Bamber D; Chohan J; Troxell R; Thode HC
    Ann Emerg Med; 2009 Apr; 53(4):528-33. PubMed ID: 18640743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
    Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
    Mayhall EA; Gray R; Lopes V; Matteson KA
    Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal obstruction in pregnancy by ondansetron.
    Cohen R; Shlomo M; Dil DN; Dinavitser N; Berkovitch M; Koren G
    Reprod Toxicol; 2014 Dec; 50():152-3. PubMed ID: 25461913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron: perioperative use of a serotonin receptor antagonist for the prevention and treatment of nausea and vomiting.
    Early TE; Charbonneau J; McKnight G; Jenkins P
    J Post Anesth Nurs; 1995 Dec; 10(6):320-3. PubMed ID: 8632370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetic use among pregnant women in the United States: the escalating use of ondansetron.
    Taylor LG; Bird ST; Sahin L; Tassinari MS; Greene P; Reichman ME; Andrade SE; Haffenreffer K; Toh S
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):592-596. PubMed ID: 28220993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
    Holdsworth MT; Raisch DW; Winter SS; Chavez CM
    Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.